Global Cord Blood Corporation

Symbol: CO

NYSE

2.9876

USD

Market price today

  • 5.2326

    P/E Ratio

  • -0.0019

    PEG Ratio

  • 400.08M

    MRK Cap

  • 0.00%

    DIV Yield

Global Cord Blood Corporation (CO) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.85%

Operating Profit Margin

0.49%

Net Profit Margin

0.40%

Return on Assets

0.06%

Return on Equity

0.11%

Return on Capital Employed

0.08%

Company general description and statistics

Sector: Healthcare
Industry: Diagnostics & Research
CEO:Ms. Ting Zheng
Full-time employees:1202
City:Central
Address:Bank of China Tower
IPO:2007-05-09
CIK:0001467808

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

General Outlook

When we look at how much money they make before expenses, they keep 0.853% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.490%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.403%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.059% return, is a testament to Global Cord Blood Corporation's adeptness in optimizing resource deployment. Global Cord Blood Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.108%. Furthermore, the proficiency of Global Cord Blood Corporation in capital utilization is underscored by a remarkable 0.077% return on capital employed.

Stock Prices

Global Cord Blood Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $2.9876, while its low point bottomed out at $2.9876. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Global Cord Blood Corporation's stock market.

Liquidity Ratios

Analyzing CO liquidity ratios reveals its financial health of the firm. The current ratio of 1072.60% gauges short-term asset coverage for liabilities. The quick ratio (1055.17%) assesses immediate liquidity, while the cash ratio (1030.22%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio1072.60%
Quick Ratio1055.17%
Cash Ratio1030.22%

Profitability Ratios

CO profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 50.50% underscores its earnings before tax deductions. The effective tax rate stands at 18.85%, revealing its tax efficiency. The net income per EBT, 79.81%, and the EBT per EBIT, 103.12%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 48.97%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin50.50%
Effective Tax Rate18.85%
Net Income per EBT79.81%
EBT per EBIT103.12%
EBIT per Revenue48.97%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 10.73, it details the span from stock purchase to revenue. The 11 days it takes to settle debts showcases its creditor relations. Meanwhile, a 10 cash conversion cycle and 770.76% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding1055
Days of Inventory Outstanding91
Operating Cycle138.71
Days of Payables Outstanding17
Cash Conversion Cycle122
Receivables Turnover7.71
Payables Turnover22.01
Inventory Turnover4.00
Fixed Asset Turnover2.61
Asset Turnover0.15

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 5.05, and free cash flow per share, 4.89, depict cash generation on a per-share basis. The cash per share value, 54.80, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.49, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share5.05
Free Cash Flow per Share4.89
Cash per Share54.80
Operating Cash Flow Sales Ratio0.49
Free Cash Flow to Operating Cash Flow Ratio0.97
Cash Flow Coverage Ratio4174.20
Short Term Coverage Ratio4174.20
Capital Expenditure Coverage Ratio31.01
Dividend Paid and Capex Coverage Ratio31.01

Debt and Leverage Ratios

An interest coverage of -15.79 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage-15.79
Cash Flow to Debt Ratio4174.20
Company Equity Multiplier1.75

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 10.23, provides a glimpse into top-line earnings distributed across each share. Net income per share, 4.12, reflects the portion of profit attributed to each share. The book value per share, 40.14, represents the net asset value distributed per share, while the tangible book value per share, 39.50, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share10.23
Net Income Per Share4.12
Book Value Per Share40.14
Tangible Book Value Per Share39.50
Shareholders Equity Per Share40.14
Interest Debt Per Share-0.32
Capex Per Share-0.16

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, -3,683,367,448.453, captures the company's total value, considering both debt and equity. Income quality, 1.20, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.15, gauges operational efficiency, while the research and development to revenue, 1.79%, highlights investment in innovation. The ratio of intangibles to total assets, 0.98%, indicates the value of non-physical assets, and capex to operating cash flow, -3.23%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value-3,683,367,448.453
Income Quality1.20
Sales General and Administrative to Revenue0.15
Research and Development to Revenue1.79%
Intangibles to Total Assets0.98%
Capex to Operating Cash Flow-3.23%
Capex to Revenue-1.59%
Capex to Depreciation-41.29%
Graham Number61.02
Return on Tangible Assets5.93%
Graham Net Net25.96
Working Capital6,288,445,000
Tangible Asset Value4,801,391,000
Net Current Asset Value3,285,450,000
Average Receivables145,800,000
Average Payables8,904,500
Average Inventory45,068,000
Days Sales Outstanding47
Days Payables Outstanding17
Days of Inventory On Hand91
ROIC10.13%
ROE0.10%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.54, and the price to book ratio, 0.54, reflect the market's valuation relative to the company's book value. The price to sales ratio, 2.32, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 4.86, and price to operating cash flows, 4.27, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.54
Price to Book Ratio0.54
Price to Sales Ratio2.32
Price Cash Flow Ratio4.27
Enterprise Value Multiple15.19
Price Fair Value0.54
Price to Operating Cash Flow Ratio4.27
Price to Free Cash Flows Ratio4.86
Price to Tangible Book Ratio0.61
Enterprise Value to Sales-2.96
Enterprise Value Over EBITDA-5.86
EV to Operating Cash Flow-6.00
Earnings Yield16.83%
Free Cash Flow Yield19.94%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Global Cord Blood Corporation (CO) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 5.233 in 2024.

What is the ticker symbol of Global Cord Blood Corporation stock?

The ticker symbol of Global Cord Blood Corporation stock is CO.

What is company IPO date?

IPO date of Global Cord Blood Corporation is 2007-05-09.

What is company current share price?

Current share price is 2.988 USD.

What is stock market cap today?

The market cap of stock today is 400084454.000.

What is PEG ratio in 2024?

The current -0.002 is -0.002 in 2024.

What is the number of employees in 2024?

In 2024 the company has 1202.